EcoVadis Platinum Level Achieved in 2026
We have renewed our EcoVadis assessment and achieved the Platinum level!
For several years now, we have been developing an ambitious CSR approach that is deeply integrated into our corporate strategy.
Our CSR strategy is built around three major commitments:
Among the year’s notable achievements: a 32% reduction in water consumption per kg of hyaluronic acid produced since 2020; a 17% decrease in greenhouse gas emissions (Scopes 1 and 2) per kg of hyaluronic acid produced between 2021 and 2025; and 97% of our critical suppliers signing the Responsible Procurement Charter.
“We are convinced that sustainable performance is built over time, through measurable actions, continuous improvement, and ongoing dialogue with our stakeholders,” emphasizes Christophe Coyard, Director of Industrial Performance in charge of CSR strategy.
On June 4th, as part of the 3rd edition of the National Biopharmaceutical Bioproduction Day (#JNBB2026) organized by France BioLead, HTL Biotechnology was pleased to open the doors of its Javené facility to students and teachers who came to learn about careers in bioproduction.
At HTL Biotechnology, a culture of safety is deeply ingrained in our daily operations and guides all of our industrial practices. It is part of a clear goal: striving for zero accidents by placing prevention at the heart of our actions.
We have renewed our EcoVadis assessment and achieved the Platinum level!